Detalhe da pesquisa
1.
In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c <â¯7% are associated with lower major cardiovascular events.
Am Heart J;
225: 97-107, 2020 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32480059
2.
Growth Differentiation Factor 15 Predicts All-Cause Morbidity and Mortality in Stable Coronary Heart Disease.
Clin Chem;
63(1): 325-333, 2017 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27811204
3.
Cardiovascular and Lifestyle Risk Factors and Cognitive Function in Patients With Stable Coronary Heart Disease.
J Am Heart Assoc;
8(7): e010641, 2019 04 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30897999
4.
Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A2 activity in atherosclerotic plaque.
Atherosclerosis;
267: 78-89, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29101839
5.
Lipoprotein-Associated Phospholipase A2 Activity Is a Marker of Risk But Not a Useful Target for Treatment in Patients With Stable Coronary Heart Disease.
J Am Heart Assoc;
5(6)2016 06 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27329448